Remedy Robotics, a developer of remote surgical robots for cardiovascular emergencies, is in talks to raise $50 million in Series B funding, two sources familiar tell Axios Pro.
Why it matters: The company, which recently powered the first fully remote, in-human neurointervention, just closed $35 million in seed and Series A financing.
